Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-914

Hi Dachopper,

nor sure why u sent to me your views the share goes to 1.05 after acceptance.

well… just to justify my views (1.40-1.50) sounds too optimistic but its not.


the msb share have two main forces.one is daily traders , especulators, gamblers etc.
a second a normal fund buys and sells based o. asx 300


the sellers will just withdraw their positions and plenty of new “punters” will come ina. Hope make few cents for 2-3-4 days.

here is the catch…

msb create a strong history of jump day one and start deop day 2 . All know that and as such people start sell on day 1.

butbthe buyers will not be short term, the buyers will be several ones that start consider this Unmet sittuation can produce a boom in entire industry .

if approved they are not just talking about the GHvD but several other ones that was obliterated from calculations and close to zero value at current share price.


1.40-q1.50 is the first leg of starting re rate the good chances of all other trials

like always just my view and not advice

cato